Metraipolis › archive › dc_d0b6ed030e61

Knockdown of TOP2A reverses cisplatin resistance in ovarian cancer by inhibiting EMT via ferroptosis mediated by the TP53/GPX4/SLC7A11 axis — Europe PMC PMID:41235254

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41235254
DOI
10.3389/fimmu.2025.1675373
License (as archived)
solo-consultazione
Archived
2026-11-08T23:18:06.000Z
SHA-256 of the archived text
a852614713be7e0821b0ba7229be21ac0d55e69036073169daae2b16ce3762ef
Stable URL of this page
https://metraipolis.com/documento/dc_d0b6ed030e61

How to cite

Knockdown of TOP2A reverses cisplatin resistance in ovarian cancer by inhibiting EMT via ferroptosis mediated by the TP53/GPX4/SLC7A11 axis — Europe PMC PMID:41235254 — Europe PMC (en), https://europepmc.org/article/MED/41235254 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d0b6ed030e61 (Metraipolis archive dc_d0b6ed030e61, sha256 a852614713be7e0821b0ba7229be21ac0d55e69036073169daae2b16ce3762ef)
BibTeX
@misc{dcd0b6ed030e61,
  title = {Knockdown of TOP2A reverses cisplatin resistance in ovarian cancer by inhibiting EMT via ferroptosis mediated by the TP53/GPX4/SLC7A11 axis — Europe PMC PMID:41235254},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41235254},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d0b6ed030e61; sha256 a852614713be7e0821b0ba7229be21ac0d55e69036073169daae2b16ce3762ef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41235254. Agents can read the archived copy with the MCP tool read_document.